Valuation : Terumo Corporation

Market Cap 3,587B 22.99B 19.78B 18.61B 17B 31.8B 2,170B 31.89B 220B 85.34B 1,114B 86.32B 84.44B P/E 2027 *
18.1x
P/E 2028 * 18.7x
Enterprise Value 3,633B 23.28B 20.03B 18.85B 17.22B 32.21B 2,198B 32.3B 223B 86.43B 1,128B 87.43B 85.52B EV / Sales 2027 *
2.89x
EV / Sales 2028 * 2.66x
Free-Float
97.07%
Yield 2027 *
1.53%
Yield 2028 * 1.67%
1 day-1.44%
1 week-4.21%
Current month-3.34%
1 month+6.29%
3 months+6.67%
6 months+23.11%
Current year+7.14%
1 week 2,420.5
Extreme 2420.5
2,555
1 month 2,280
Extreme 2280
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,696.5
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-4.21%-8.07%+11.30% 22.99B
-0.42%-3.68%-18.51%+7.39% 187B
+1.15%+3.22%+1.37%+17.42% 120B
-1.86%+2.77%+13.15%+91.44% 63.15B
-1.31%-1.09%+17.67%+43.65% 51.75B
-1.54%-2.52%-3.98%-32.30% 50.32B
-2.02%-3.22%+9.18%-12.39% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-15.78% 23.93B
-0.69%-3.93%-8.44%+0.42% 21.9B
Average -0.89%-0.46%+4.22%+12.35% 60.72B
Weighted average by Cap. -0.56%-0.12%-1.70%+16.30%

Financials

2027 *2028 *
Net sales 1,259B 8.07B 6.94B 6.53B 5.97B 11.16B 762B 11.19B 77.16B 29.94B 391B 30.29B 29.63B 1,339B 8.58B 7.38B 6.95B 6.35B 11.87B 810B 11.9B 82.08B 31.85B 416B 32.22B 31.51B
Net income 195B 1.25B 1.07B 1.01B 924M 1.73B 118B 1.73B 11.95B 4.64B 60.51B 4.69B 4.59B 192B 1.23B 1.06B 995M 909M 1.7B 116B 1.71B 11.76B 4.56B 59.55B 4.62B 4.52B
Net Debt 45.99B 295M 254M 239M 218M 408M 27.83B 409M 2.82B 1.09B 14.28B 1.11B 1.08B -26.39B -169M -146M -137M -125M -234M -15.97B -235M -1.62B -628M -8.19B -635M -621M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
04/09/26 ¥2,432.00 -1.44% 3,436,100
03/09/26 ¥2,467.50 -0.06% 3,345,100
02/09/26 ¥2,469.00 -2.97% 4,819,400
01/09/26 ¥2,544.50 +1.13% 2,819,800
31/08/26 ¥2,516.00 -0.91% 5,581,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,432.00JPY
Average target price
3,140.77JPY
Spread / Average Target
+29.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock